240 related articles for article (PubMed ID: 14512308)
1. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.
Kokame K; Matsumoto M; Fujimura Y; Miyata T
Blood; 2004 Jan; 103(2):607-12. PubMed ID: 14512308
[TBL] [Abstract][Full Text] [Related]
2. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
Zhou W; Tsai HM
Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
Cruz MA; Whitelock J; Dong JF
Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
[TBL] [Abstract][Full Text] [Related]
4. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
Wu JJ; Fujikawa K; McMullen BA; Chung DW
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18470-4. PubMed ID: 17121983
[TBL] [Abstract][Full Text] [Related]
6. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
Zhou W; Bouhassira EE; Tsai HM
Blood; 2007 Aug; 110(3):886-93. PubMed ID: 17426255
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of recombinant human ADAMTS-13.
Plaimauer B; Scheiflinger F
Semin Hematol; 2004 Jan; 41(1):24-33. PubMed ID: 14727256
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Moake JL
Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
[TBL] [Abstract][Full Text] [Related]
13. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
Kokame K; Miyata T
Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells.
López JA; Dong JF
Semin Hematol; 2004 Jan; 41(1):15-23. PubMed ID: 14727255
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
Obert B; Tout H; Veyradier A; Fressinaud E; Meyer D; Girma JP
Thromb Haemost; 1999 Nov; 82(5):1382-5. PubMed ID: 10595622
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
Whitelock JL; Nolasco L; Bernardo A; Moake J; Dong JF; Cruz MA
J Thromb Haemost; 2004 Mar; 2(3):485-91. PubMed ID: 15009467
[TBL] [Abstract][Full Text] [Related]
18. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
20. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
